A detailed history of Davis R M Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Davis R M Inc holds 840 shares of VRTX stock, worth $378,814. This represents 0.01% of its overall portfolio holdings.

Number of Shares
840
Previous 830 1.2%
Holding current value
$378,814
Previous $389,000 0.26%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $4,600 - $5,057
10 Added 1.2%
840 $390,000
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $130,805 - $161,681
333 Added 67.0%
830 $389,000
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $2,038 - $2,230
5 Added 1.02%
497 $207,000
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $168,756 - $202,054
492 New
492 $200,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Davis R M Inc Portfolio

Follow Davis R M Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.